Human tumor cells segregate into radiosensitivity groups that associate with ATM and TP53 status

References

• Puck TT, Marcus PI. Action of X-rays on mammalian cells. J Exp Med 1956; 103: 653–66
   PubMed Web of Science ®Google Scholar
• Thames HD, Jr, Withers HR, Fletcher GH. Changes in early and late radiation responses with altered dose fractionation: Impliations for dose-survival relationships. Int J Radiat Oncol Biol Phys 1982; 8: 219–26
   PubMed Web of Science ®Google Scholar
• Fowler JF. The linear-quadratic model and progress in fractionated radiotherapy. Br J Radiol 1989; 62: 679–94
   PubMed Web of Science ®Google Scholar
• Fowler JF. Dose-response curves for organ function in cell survival. Br J Radiol 1983; 56: 497–500
   PubMed Web of Science ®Google Scholar
• Hall, E. Radiobiology for the Radiologist. Chapter 3. Philadelphia: JB Lippincott; 1994.
   Google Scholar
• Malaise EP, Fertil B, Chavaudra N, Guichard M. Distribution of radiation sensitivities for human tumor cells of specific histological types: Comparison of in vitro to in vivo data. Int J Radiat Oncol Biol Phys 1986; 12: 617–24
   PubMed Web of Science ®Google Scholar
• West CM, Davidson SE, Roberts SA, Hunter RD. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer 1997; 76: 1184–90
   PubMed Web of Science ®Google Scholar
• Friedberg EC, Walker GC, Siede W. DNA Repair and Mutagenesis. ASM Press, Washington 1995
   Google Scholar
• Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in cellular response to DNA damage. Cancer Res 1991; 51: 6304–11
   PubMed Web of Science ®Google Scholar
• Bristow RG, Benchimol S, Hill RP. The p53 gene as a modifier of intrinsic radiosensitivity: Implications for radiotherapy. Radiother Oncol 1996; 40: 197–223
   PubMed Web of Science ®Google Scholar
• Dahm-Daphi J. p53: Biology and role for cellular radiosensitivity. Strahlenther Onkol 2000; 176: 278–85
   PubMed Web of Science ®Google Scholar
• Matsui Y, Tscuchida Y, Keng PC. Effects of p53 mutations on cellular sensitivity to ionizing radiation. Am J Clin Oncol 2001; 24: 486–90
   PubMed Web of Science ®Google Scholar
• Weber KJ, Wenz F. p53, apoptosis and radiosensitivity–experimental and clinical data. Onkologie 2002; 25: 136–41
   PubMedGoogle Scholar
• Danielsen T, Smith-Sorensen B, Gronland HA, Hvidsten M, Barrensen-Dale AL, Rofstad EK. No association between radiosensitivyt and TP53 status, G1 arrest or in levels of p53, myc, ras or raf in human melanoma lines. Int J Radiat Biol 1999; 75: 1149–60
   PubMed Web of Science ®Google Scholar
• Kandolier D, Zwrtk R, Ludwig C. TP53 genotype but not p53 immunohistochemistry results predicts response to preoperative short-term radiotherapy in operative rectal cancer. Ann Surg 2002; 235: 493–8
   PubMedGoogle Scholar
• Robles AI, Linke SP, Harris CC. The p53 network in lung carcinogenesis. Oncogene 2002; 21: 6898–907
   PubMed Web of Science ®Google Scholar
• Bunz F, Hwang PM, Torrance C, Waldmann T, Zhang Y, Dillehay L, et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Inv 1999; 104: 263–9
   PubMed Web of Science ®Google Scholar
• Han TA, Hermeking H, Lengauer C, Janschek E, Ploner M, Hofbauer F, et al. 14-3-3σ is required to prevent mitotic catastrophe after DNA damage. Nature 1999; 401: 616–20
   PubMedGoogle Scholar
• Waldman T, Zhang Y, Dillehay LE, Yu J, Kinzler K, Vogelstein B, et al. Cell cycle arrest vs. cell death in cancer therapy. Nat Med 1997; 3: 1034–6
   PubMed Web of Science ®Google Scholar
• Sklar MD. The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science 1998; 239: 645–7
   Web of Science ®Google Scholar
• Tribius S, Pidel A, Casper D. ATM protein expression correlates with radioresistance in primary glioblastoma cells in culture. Int J Radiat Oncol Biol Phys 2001; 50: 511–23
   PubMed Web of Science ®Google Scholar
• Koi M, Umar A, Chauhan DP, et al. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res 1994; 54: 4308–12
   PubMed Web of Science ®Google Scholar
• Chapman JD. Single hit mechanism of tumour cell killing by radiation. Int J Radiat Biol 2003; 79: 71–81
   PubMed Web of Science ®Google Scholar
• Allison SG, Milner J. Remodelling chromatain on a global scale: A novel protective effect of p53. Carcinogenesis 2004; 25: 1551–7
   PubMed Web of Science ®Google Scholar